98 related articles for article (PubMed ID: 1070434)
1. [Cancer immunotherapy].
Kaartinen M; Mäkelä O
Duodecim; 1976; 92(24):1364-9. PubMed ID: 1070434
[No Abstract] [Full Text] [Related]
2. Immunotherapy of cancer.
Salmon SE; Jones SE
Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
[No Abstract] [Full Text] [Related]
3. [15 cases of immunotherapy of cancer].
Serrou B; Solassol C; Pujol H; Romieu C
Nouv Presse Med; 1972 Jan; 1(3):197. PubMed ID: 4551478
[No Abstract] [Full Text] [Related]
4. Introduction: Immunotherapy of cancer in man, a reality.
Klein E
Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
[No Abstract] [Full Text] [Related]
5. Current status of the immunotherapy of cancer.
N Z Med J; 1974 Apr; 79(513):874-5. PubMed ID: 4527726
[No Abstract] [Full Text] [Related]
6. [Immunotherapy of cancer: evolution of concepts and clinical advances].
Baldwin RW
Rev Prat; 1980 Jan; 30(5):221-4, 227-8. PubMed ID: 6929557
[No Abstract] [Full Text] [Related]
7. Immunotherapy: the unfulfilled promise.
Greco RS
J Med Soc N J; 1981 Jan; 78(1):32-5. PubMed ID: 7021843
[No Abstract] [Full Text] [Related]
8. Administration of prostaglandins A and E and antiinflammatory drugs to patients with cancer.
Powles TJ
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():327-31. PubMed ID: 6133423
[No Abstract] [Full Text] [Related]
9. Mathematical modelling and clinical trials.
Jackson RR; Hughes DJ
Experientia Suppl; 1982; 41():327-37. PubMed ID: 6958522
[No Abstract] [Full Text] [Related]
10. Implications of survival curve slopes on the interpretation of adjuvant therapy results.
Eriguchi M; Mathé G
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():93-7. PubMed ID: 3074230
[No Abstract] [Full Text] [Related]
11. Implications of survival curve slopes on the interpretation of adjuvant therapy results.
Eriguchi M; Mathé G
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):93-7. PubMed ID: 2743534
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase immunotherapy of tumors in man.
Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
[No Abstract] [Full Text] [Related]
13. Immunotherapy of patients with cancer.
Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
[No Abstract] [Full Text] [Related]
14. Immunotherapeutic approaches to the management of neoplasms.
Klein E; Holtermann OA
Natl Cancer Inst Monogr; 1972 Dec; 35():379-402. PubMed ID: 4572833
[No Abstract] [Full Text] [Related]
15. The anti-idiotype vaccines for immunotherapy.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
[TBL] [Abstract][Full Text] [Related]
16. New survival curve model for comparison of adjuvant therapy of malignant diseases.
Eriguchi M; Mathé G
Biomed Pharmacother; 1986; 40(4):143-7. PubMed ID: 3790708
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of cancer: theory and practice.
Rapp HJ
Proc Inst Med Chic; 1975; 30(8):251-5, 274. PubMed ID: 1103122
[No Abstract] [Full Text] [Related]
18. [Present state of immunotherapy of tumours (author's transl)].
Rieche K
Arch Geschwulstforsch; 1974; 44(2):167-81. PubMed ID: 4375452
[No Abstract] [Full Text] [Related]
19. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
Grigorovich NA; Risina DIa; Nodel'son SE
Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
